A detailed history of Northwestern Mutual Wealth Management CO transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 5,000 shares of AMRN stock, worth $2,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,000 -0.0%
Holding current value
$2,600
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$0.63 - $1.07 $182 - $310
-290 Reduced 5.48%
5,000 $3,000
Q1 2024

May 15, 2024

BUY
$0.82 - $1.35 $237 - $391
290 Added 5.8%
5,290 $4,000
Q4 2023

Feb 13, 2024

BUY
$0.66 - $0.91 $3,300 - $4,550
5,000 New
5,000 $4,000
Q1 2023

May 15, 2023

BUY
$1.19 - $2.19 $224 - $413
189 Added 5.9%
3,390 $5,000
Q1 2022

May 09, 2022

SELL
$2.85 - $3.73 $101,175 - $132,415
-35,500 Reduced 91.73%
3,201 $11,000
Q4 2021

Feb 03, 2022

BUY
$3.24 - $5.18 $123,771 - $197,881
38,201 Added 7640.2%
38,701 $131,000
Q3 2021

Nov 15, 2021

BUY
$3.94 - $5.84 $1,970 - $2,920
500 New
500 $3,000
Q2 2021

Aug 13, 2021

SELL
$4.26 - $6.5 $2,130 - $3,250
-500 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$5.03 - $8.8 $2,515 - $4,400
500 New
500 $3,000
Q4 2020

Feb 12, 2021

SELL
$4.04 - $5.31 $1,212 - $1,592
-300 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$4.0 - $21.53 $1,200 - $6,459
300 New
300 $1,000
Q1 2019

May 10, 2019

SELL
$12.61 - $22.33 $5,460 - $9,668
-433 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$12.41 - $22.98 $5,373 - $9,950
433 New
433 $6,000
Q2 2018

Aug 10, 2018

SELL
$2.68 - $3.48 $5,896 - $7,656
-2,200 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$2.99 - $4.44 $5,980 - $8,880
2,000 Added 1000.0%
2,200 $7,000
Q2 2017

Aug 10, 2017

BUY
N/A
200
200 $1,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $210M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.